The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Harmonization
2019-20 coronavirus outbreak
DOI:
10.1101/2022.02.27.22271399
Publication Date:
2022-03-01T16:44:06Z
AUTHORS (59)
ABSTRACT
In October 2020, the National Cancer Institute (NCI) Serological Sciences Network (SeroNet) was established to study immune response COVID-19, and "to develop, validate, improve, implement serological testing associated technologies." SeroNet is comprised of 25 participating research institutions partnering with Frederick Laboratory for Research (FNLCR) Coordinating Center. Since its inception, has supported collaborative development sharing COVID-19 assay procedures set forth plans harmonization.To facilitate collaboration procedure sharing, a detailed survey sent collate comprehensive details performance metrics on assays within SeroNet. addition, FNLCR protocol calibrate reference standards, such as U.S. SARS-CoV-2 serology standard material First WHO International Standard (IS) anti-SARS-CoV-2 immunoglobulin (20/136), harmonization reporting units cross-comparison data.SeroNet reported total 27 ELISA methods, 13 multiplex assays, 9 neutralization use 12 different commercial methods. developed standardized these diverse standards.SeroNet have array virus vaccines. Calibration harmonize results will future pooled data analyses cross-comparisons.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....